The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history
出版年份 2020 全文链接
标题
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history
作者
关键词
-
出版物
BRAIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-04-23
DOI
10.1093/brain/awaa145
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- Multiple sclerosis: effect of beta interferon treatment on survival
- (2019) Elaine Kingwell et al. BRAIN
- Epidemiology and treatment of multiple sclerosis in elderly populations
- (2019) Caila B. Vaughn et al. Nature Reviews Neurology
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
- (2019) William Camu et al. Neurology-Neuroimmunology & Neuroinflammation
- A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes
- (2019) Karen K. Chung et al. ANNALS OF NEUROLOGY
- Smoking and worsening disability in multiple sclerosis: A meta-analysis
- (2018) P. Heydarpour et al. ACTA NEUROLOGICA SCANDINAVICA
- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
- (2018) Sabina Luchetti et al. ACTA NEUROPATHOLOGICA
- Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis
- (2018) R. Zivadinov et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI
- (2018) M. Absinta et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Prodromal symptoms of multiple sclerosis in primary care
- (2018) Giulio Disanto et al. ANNALS OF NEUROLOGY
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
- (2018) Clara Matute-Blanch et al. BRAIN
- Early versus later treatment start in multiple sclerosis: a register-based cohort study
- (2018) T. A. Chalmer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
- (2018) Kjetil Bjornevik et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Smoking affects the interferon beta treatment response in multiple sclerosis
- (2018) Eva R. Petersen et al. NEUROLOGY
- Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
- (2018) Nils Koch-Henriksen et al. NEUROLOGY
- Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
- (2018) Kjetil Bjornevik et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
- (2018) Eva Rosa Petersen et al. Multiple Sclerosis Journal
- Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome
- (2018) Roos M. van der Vuurst de Vries et al. JAMA Neurology
- Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis
- (2018) Jordana Hughes et al. JAMA Neurology
- Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study
- (2018) J. Lorscheider et al. EUROPEAN JOURNAL OF NEUROLOGY
- Vitamin D for the treatment of multiple sclerosis: a meta-analysis
- (2018) Laurie McLaughlin et al. JOURNAL OF NEUROLOGY
- Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan
- (2017) H. Houzen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume
- (2017) Daniel M. Harrison et al. JOURNAL OF NEUROIMAGING
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
- (2017) Alessio Signori et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome should be treated with disease-modifying therapy – Yes
- (2017) Darin T Okuda Multiple Sclerosis Journal
- Radiologically isolated syndrome should be treated with disease-modifying therapy – No
- (2017) Andrés Labiano-Fontcuberta et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
- (2017) Johannes Lorscheider et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
- (2017) Richard A. Nash et al. NEUROLOGY
- Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
- (2017) Sarah Burkill et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
- (2017) Alessio Signori et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome should be treated with disease-modifying therapy – Yes
- (2017) Darin T Okuda Multiple Sclerosis Journal
- Radiologically isolated syndrome should be treated with disease-modifying therapy – No
- (2017) Andrés Labiano-Fontcuberta et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study
- (2017) K. O’Connell et al. Multiple Sclerosis and Related Disorders
- Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
- (2017) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
- (2016) Assunta Dal-Bianco et al. ACTA NEUROPATHOLOGICA
- An updated histological classification system for multiple sclerosis lesions
- (2016) Tanja Kuhlmann et al. ACTA NEUROPATHOLOGICA
- Incidence of Radiologically Isolated Syndrome: A Population-Based Study
- (2016) Y. Forslin et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Predictors of long-term disability accrual in relapse-onset multiple sclerosis
- (2016) Vilija G. Jokubaitis et al. ANNALS OF NEUROLOGY
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
- (2016) Nathaniel Lizak et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The importance of studying sex differences in disease: The example of multiple sclerosis
- (2016) Lisa C. Golden et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Radiologically isolated syndrome: An update on a rare entity
- (2016) Andrés Labiano-Fontcuberta et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Importance of early treatment initiation in the clinical course of multiple sclerosis
- (2016) Andrius Kavaliunas et al. Multiple Sclerosis Journal
- The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
- (2016) Pascal Sati et al. Nature Reviews Neurology
- Increased total sodium concentration in gray matter better explains cognition than atrophy in MS
- (2016) Adil Maarouf et al. NEUROLOGY
- The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
- (2016) Ludwig Kappos et al. NEUROLOGY
- Radiologically isolated syndrome: An update on a rare entity
- (2016) Andrés Labiano-Fontcuberta et al. Multiple Sclerosis Journal
- Importance of early treatment initiation in the clinical course of multiple sclerosis
- (2016) Andrius Kavaliunas et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab
- (2016) Julie Hejgaard Laursen et al. Multiple Sclerosis and Related Disorders
- Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- (2015) Mar Tintore et al. BRAIN
- Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
- (2015) Ali Manouchehrinia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
- (2015) Ludwig Kappos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial
- (2015) L. Kappos et al. NEUROLOGY
- Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
- (2015) Kathryn C. Fitzgerald et al. JAMA Neurology
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
- (2015) Karen Ann Ribbons et al. PLoS One
- Gender effects on treatment response to interferon-beta in multiple sclerosis
- (2014) M. Magyari et al. ACTA NEUROLOGICA SCANDINAVICA
- Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
- (2014) Joachim Burman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Sodium intake is associated with increased disease activity in multiple sclerosis
- (2014) Mauricio F Farez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- (2014) Thomas P Leist et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
- (2014) Darin T. Okuda et al. PLoS One
- Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
- (2014) Alberto Ascherio et al. JAMA Neurology
- Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis
- (2013) T. Gabelic et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Randomized study combining interferon and glatiramer acetate in multiple sclerosis
- (2013) Fred D. Lublin et al. ANNALS OF NEUROLOGY
- Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
- (2013) Tomas Kalincik et al. BRAIN
- Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
- (2013) Ali Manouchehrinia et al. BRAIN
- Clinical impact of early brain atrophy in clinically isolated syndromes
- (2013) F Pérez-Miralles et al. Multiple Sclerosis Journal
- The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis
- (2013) Eleanor James et al. Multiple Sclerosis Journal
- ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)
- (2012) Øivind Torkildsen et al. ARCHIVES OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Clinically isolated syndromes
- (2012) David H Miller et al. LANCET NEUROLOGY
- Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique
- (2012) Devon S Conway et al. Multiple Sclerosis Journal
- Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort
- (2012) C Lebrun et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome – incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review
- (2012) Tobias Granberg et al. Multiple Sclerosis Journal
- Association of MRI metrics and cognitive impairment in radiologically isolated syndromes
- (2012) M. P. Amato et al. NEUROLOGY
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
- (2011) Alasdair J Coles et al. LANCET NEUROLOGY
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
- (2011) Giancarlo Comi et al. LANCET NEUROLOGY
- Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis
- (2011) MB D’hooghe et al. Multiple Sclerosis Journal
- Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
- (2011) D. T. Okuda et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple Sclerosis
- (2011) Nicola De Stefano et al. PLoS One
- Imaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging
- (2010) David Pitt et al. ARCHIVES OF NEUROLOGY
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Cognitive function in radiologically isolated syndrome
- (2010) Christine Lebrun et al. Multiple Sclerosis Journal
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
- (2009) M. Trojano et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential
- (2009) Christine Lebrun ARCHIVES OF NEUROLOGY
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
- (2009) Per Soelberg Sorensen et al. LANCET NEUROLOGY
- Will Rogers phenomenon in multiple sclerosis
- (2008) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile
- (2008) C Lebrun et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome
- (2008) D. T. Okuda et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started